OrbiMed Advisors

OrbiMed Advisors is an investment firm specializing in the healthcare sector, providing financing solutions and expertise to foster innovation and enhance patient outcomes. With a history spanning over 25 years, OrbiMed invests in a broad range of healthcare companies, from early-stage ventures to large multinational corporations. The firm manages around $17 billion in assets, encompassing both public and private investments worldwide. OrbiMed’s diverse portfolio includes notable companies such as ADARx Pharmaceuticals, SpringWorks Therapeutics, Treeline Biosciences, and TytoCare. Operating from 12 global locations, OrbiMed has a robust team of over 130 professionals and has successfully facilitated over 130 venture-backed IPOs, demonstrating its significant impact on the healthcare industry.